Eoflow Terminates M&A Contract with Medtronic: CEO Kim Jae-jin Talks Future Plans and Legal Battles
Eoflow Terminates Merger and Acquisition Contract with Medtronic Eoflow, led by CEO Kim Jae-jin, has announced the termination of its company merger and acquisition (M&A) contract with Medtronic, a developer of wearable medical devices. Medtronic had originally planned to participate in EOflow’s 314.9 billion won paid-up capital increase and purchase 169.2 billion won worth of […]
K medical device companies targeted for global M&A… “Technology and growth are attractive”
Domestic medical device companies are attracting attention as they are receiving love calls from global companies one after another based on their outstanding technological competitiveness. Although new drug development bioenterprises are a model of global entry primarily through technology transfer (L/O), medical device companies that have commercialized products and are already generating sales are characterized […]
